Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.

Erika Richtig; H Peter Soyer; Martin Posch; Ulrike Mossbacher; Peter Bauer; Ligia Teban; Gerhard Svolba; Ingrid H Wolf; Peter Fritsch; Bernhard Zelger; Beatrix Volc-Platzer; Walter Gebhart; Paul Mischer; Andreas Steiner; Wolf Pachinger; Helmut Hintner; Friedrich Gschnait; Klemens Rappersberger; Peter Pilarski; Hubert Pehamberger

doi:10.1200/JCO.2004.00.8128

Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.

Erika Richtig, H Peter Soyer, Martin Posch, Ulrike Mossbacher, Peter Bauer, Ligia Teban, Gerhard Svolba, Ingrid H Wolf, Peter Fritsch, Bernhard Zelger, Beatrix Volc-Platzer, Walter Gebhart, Paul Mischer, Andreas Steiner, Wolf Pachinger, Helmut Hintner, Friedrich Gschnait, Klemens Rappersberger, Peter Pilarski, Hubert Pehamberger

Universitätsklinik für Dermatologie und Allergologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

22 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	8655-8663
Fachzeitschrift	JOURNAL OF CLINICAL ONCOLOGY
Jahrgang	23
Ausgabenummer	34
DOIs	https://doi.org/10.1200/JCO.2004.00.8128
Publikationsstatus	Veröffentlicht - 2005

Zugriff auf Dokument

10.1200/JCO.2004.00.8128

Dieses zitieren

Richtig, E., Soyer, H. P., Posch, M., Mossbacher, U., Bauer, P., Teban, L., Svolba, G., Wolf, I. H., Fritsch, P., Zelger, B., Volc-Platzer, B., Gebhart, W., Mischer, P., Steiner, A., Pachinger, W., Hintner, H., Gschnait, F., Rappersberger, K., Pilarski, P., & Pehamberger, H. (2005). Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group. JOURNAL OF CLINICAL ONCOLOGY , 23(34), 8655-8663. https://doi.org/10.1200/JCO.2004.00.8128

Richtig, Erika ; Soyer, H Peter ; Posch, Martin et al. / Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group. in: JOURNAL OF CLINICAL ONCOLOGY 2005 ; Jahrgang 23, Nr. 34. S. 8655-8663.

@article{23fa5410cd1c4882ba3f89915b27893d,

title = "Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.",

keywords = "SQUAMOUS-CELL CARCINOMA, HIGH-RISK MELANOMA, HIGH-DOSE INTERFERON-ALPHA-2B, SOUTHWEST-ONCOLOGY-GROUP, 13-CIS-RETINOIC ACID, MALIGNANT-MELANOMA, RETINOIC ACID, METASTATIC MELANOMA, CUTANEOUS MELANOMA, CLINICAL-TRIAL",

author = "Erika Richtig and Soyer, \{H Peter\} and Martin Posch and Ulrike Mossbacher and Peter Bauer and Ligia Teban and Gerhard Svolba and Wolf, \{Ingrid H\} and Peter Fritsch and Bernhard Zelger and Beatrix Volc-Platzer and Walter Gebhart and Paul Mischer and Andreas Steiner and Wolf Pachinger and Helmut Hintner and Friedrich Gschnait and Klemens Rappersberger and Peter Pilarski and Hubert Pehamberger",

year = "2005",

doi = "10.1200/JCO.2004.00.8128",

language = "English",

volume = "23",

pages = "8655--8663",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

number = "34",

}

Richtig, E, Soyer, HP, Posch, M, Mossbacher, U, Bauer, P, Teban, L, Svolba, G, Wolf, IH, Fritsch, P, Zelger, B, Volc-Platzer, B, Gebhart, W, Mischer, P, Steiner, A, Pachinger, W, Hintner, H, Gschnait, F, Rappersberger, K, Pilarski, P & Pehamberger, H 2005, 'Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.', JOURNAL OF CLINICAL ONCOLOGY , Jg. 23, Nr. 34, S. 8655-8663. https://doi.org/10.1200/JCO.2004.00.8128

Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group. / Richtig, Erika; Soyer, H Peter; Posch, Martin et al.
in: JOURNAL OF CLINICAL ONCOLOGY , Jahrgang 23, Nr. 34, 2005, S. 8655-8663.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.

AU - Richtig, Erika

AU - Soyer, H Peter

AU - Posch, Martin

AU - Mossbacher, Ulrike

AU - Bauer, Peter

AU - Teban, Ligia

AU - Svolba, Gerhard

AU - Wolf, Ingrid H

AU - Fritsch, Peter

AU - Zelger, Bernhard

AU - Volc-Platzer, Beatrix

AU - Gebhart, Walter

AU - Mischer, Paul

AU - Steiner, Andreas

AU - Pachinger, Wolf

AU - Hintner, Helmut

AU - Gschnait, Friedrich

AU - Rappersberger, Klemens

AU - Pilarski, Peter

AU - Pehamberger, Hubert

PY - 2005

Y1 - 2005

KW - SQUAMOUS-CELL CARCINOMA

KW - HIGH-RISK MELANOMA

KW - HIGH-DOSE INTERFERON-ALPHA-2B

KW - SOUTHWEST-ONCOLOGY-GROUP

KW - 13-CIS-RETINOIC ACID

KW - MALIGNANT-MELANOMA

KW - RETINOIC ACID

KW - METASTATIC MELANOMA

KW - CUTANEOUS MELANOMA

KW - CLINICAL-TRIAL

U2 - 10.1200/JCO.2004.00.8128

DO - 10.1200/JCO.2004.00.8128

M3 - Original Article

C2 - 16260701

SN - 0732-183X

VL - 23

SP - 8655

EP - 8663

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 34

ER -

Richtig E, Soyer HP, Posch M, Mossbacher U, Bauer P, Teban L et al. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group. JOURNAL OF CLINICAL ONCOLOGY . 2005;23(34):8655-8663. doi: 10.1200/JCO.2004.00.8128